Israel
Convergent RnR Ltd. is a biotechnology and healthcare startup based in Israel. Since its founding in 2010, the company has gained attention with its revolutionary AI-driven robotic radiation platform, heralded with the slogan "A NEW APPROACH TO ONCOLOGY RADIOTHERAPY." This innovative technology aims to reduce non-therapeutic dose to adjacent critical structures, thereby disrupting the stagnant radiation therapy/surgery equipment market.
The unique convergence of low energy x-ray beam provided by CRNR fulfills the unmet promise of proton beam therapy. This approach offers a less toxic radiation solution with a significantly lower cost, while also eliminating the need for a concrete bunker, thereby reducing the total cost of ownership.
Notably, CRNR had a recent investment milestone in its journey with a $1.20M Venture Round investment on 17 December 2011. The investors behind this venture round are yet to be disclosed.
